Quart Barry D sold KNSA
April 28, 2026 · Form 4 insider transaction
Quart Barry D sold 13,099 shares of Kiniksa Pharmaceuticals International, plc at $50.10 per share, a transaction worth $656.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
13,099
Price
$50.10
Total value
$656.3K
InsiderQuart Barry D
RoleDirector
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateApril 28, 2026
Filing dateApril 29, 2026
Shares owned after12,546
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.; This transaction was executed in multiple trades through a broker-dealer at prices ranging between $50.00 and $50.725. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.